American multinational pharmaceutical corporation
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder : The Food and Drug Administration on Friday approved Pfizer’s treatment for a ...
cnbc.com/2024/04/26/fda-approves-pfizer-gene-therapy-beqvez-for-treatment-of-hemophilia-b.html
Quick Glance: FDA approves Pfizer’s gene therapy for hemophilia B
- The FDA has approved Pfizer's first gene therapy drug for a rare inherited bleeding disorder.
- Beqvez, a unique gene therapy drug by Pfizer, has been approved for adults with moderate to severe hemophilia B.
- The drug enables patients to produce Factor IX themselves to prevent and control bleeding.
- Pfizer is competing with a similar treatment from CSL Behring and planning more gene therapies for various genetic disorders.
Pfizer vs Moderna battle over COVID vaccine patents begins in UK: Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-vs-moderna-battle-over-covid-vaccine-patents-begins-uk-2024-04-23/
Dividend Harvesting Portfolio Week 164: $16,400 Allocated, $1,466.94 In Projected Dividends
seekingalpha.com/article/4685001-dividend-harvesting-portfolio-week-164-16400-allocated-1466-94-in-projected-dividends
Paid articlePaid
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.: Pfizer’s patent expirations are great for humanity but terrible for investors ...
barrons.com/articles/big-pharma-stocks-investors-mistakes-90e3c575
Paid articlePaid Pfizer’s patent expirations are great for humanity but terrible for investors. The same can be said for Johnson & Johnson, Merck, and Bristol Myers.
Ad group WPP trails rivals with decline in organic revenue: Britain's WPP became a clear laggard among global ad companies with a drop in organic revenue drop in ...
reuters.com/business/media-telecom/ad-group-wpp-reports-16-drop-first-quarter-organic-growth-2024-04-25/
Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment: Despite the setbacks, Zoetis' core business remains strong, with robust top-line and ...
seekingalpha.com/article/4683713-despite-lawsuit-risks-zoetis-stock-remains-compelling-investment
Paid articlePaid
Paxlovid COVID Treatment Is Most Beneficial for Unvaccinated People with Risk Factors. Others May Not Need It
scientificamerican.com/article/paxlovid-covid-treatment-most-beneficial-for-unvaccinated-people-with-risk/
Young Adults May Soon Be Able to Get an RSV Shot: After a promising trial of Abrysvo in younger adults, Pfizer plans to apply for wider U.S. approval.
time.com/6965155/rsv-vaccine-adults/
The Best Defensive Stocks to Buy: These 10 defensive stocks supply investors with reliable earnings, and often dividends, when markets look uncertain.
morningstar.com/stocks/best-defensive-stocks-buy
The Dangers of Recreational Viagra: Recreational use of Viagra without erectile dysfunction is not safe. Risks include mild side effects ...
health.clevelandclinic.org/recreational-viagra
Zoetis (ZTS) Sinks Most in 17 Months After Report on Pet Arthritis Drugs: Zoetis Inc. tumbled on Friday after a news report detailed safety concerns associated ...
bloomberg.com/news/articles/2024-04-12/zoetis-sinks-most-in-17-months-after-report-on-pet-arthritis-drugs
Paid articlePaid Pfizer wins pause on Moderna's COVID-19 patent lawsuit: Moderna's patent lawsuit claiming Pfizer and BioNTech copied its COVID-19 vaccine technology will be put ...
reuters.com/legal/litigation/pfizer-wins-pause-modernas-covid-19-patent-lawsuit-2024-04-12/
"Misleading claims": The UK audit authority criticizes the pharmaceutical company Pfizer. The vaccine against Covid-19 was illegally advertised on social media ...
weltwoche.ch/daily/irrefuehrende-behauptungen-die-britische-pruefbehoerde-kritisiert-den-pharmakonzern-pfizer-in-den-sozialen-medien-sei-illegal-fuer-den-impfstoff-gegen-covid-19-geworben-worden/
Angela Hwang, former Chief Commercial Officer & President of Global Biopharmaceuticals Business at Pfizer, discusses the launch of the Covid-19 vaccine ... Show more
CNBC Changemakers
CNBC Changemakers
Goldman Sachs: The Best Dividend Growth Stocks for Investors to Watch Now: Goldman Sachs recommends high-dividend stocks for 2024 with over 6% growth.
boerse-online.de/nachrichten/aktien/goldman-sachs-die-besten-dividendenwachstumsaktien-die-fuer-anleger-jetzt-interessant-sind-20355982.html
California sets long-awaited drinking water limit for ‘Erin Brockovich’ contaminant
orlandosentinel.com/2024/04/17/california-sets-long-awaited-drinking-water-limit-for-erin-brockovich-contaminant/
Drugmakers' low U.S. taxes belie their high sales: Most of the largest pharmaceutical companies report losing money in the United States ...
npr.org/sections/health-shots/2024/04/15/1244876740/drugmakers-low-taxes-us
Zoetis Stock Dives On Report Arthritis Shots Sickened Dogs, Cats: Zoetis stock crumbled Friday after a report suggested the company's arthritis shots ...
investors.com/news/technology/zoetis-stock-arthritis-shots-librela-solensia/
Were COVID-19 Vaccines to Blame for Infertility? Heart Attacks? A New Report Weighs In
usnews.com/news/health-news/articles/2024-04-16/were-covid-19-vaccines-to-blame-for-infertility-heart-attacks-a-new-report-weighs-in
Now the EU public prosecutor's office is also investigating von der Leyen - and the German media is still silent - The World Week
weltwoche.de/daily/nun-ermittelt-auch-die-eu-staatsanwaltschaft-gegen-von-der-leyen-und-die-deutschen-medien-schweigen-noch-immer/
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.: Pfizer’s patent expirations are great for humanity but terrible for investors ...
barrons.com/articles/big-pharma-stocks-investors-mistakes-90e3c575
Paid articlePaid
The 2024 Forbes Entrepreneurial CMO 50 List: By The Numbers: The data and details behind the CMOs and marketers making the 2024 Forbes Entrepreneurial CMO 50 ...
forbes.com/sites/sethmatlins/2024/04/15/the-2024-forbes-entrepreneurial-cmo-50-list-by-the-numbers/
Pfizer RSV Vaccine Could Get Wider Use. New Study Suggests a Benefit For All Adults.
barrons.com/articles/pfizer-fda-rsv-vaccine-shot-gsk-moderna-4b1d50cc
Paid articlePaid
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
qz.com/novavax-covid19-mrna-1851410267
Quick Glance: Criticism of Novavax for Missed Opportunities in Boosting COVID-19 Vaccine Sales
- Shah Capital called for immediate changes in the company's board.
- The activist hedge fund Shah Capital criticized Novavax's leadership for not capitalizing on concerns some individuals have about mRNA vaccines to increase sales of its traditional, protein-based COVID-19 vaccine.
- Findings from a survey of 1,500 Americans by the Annenberg Public Policy Center (APPC) at the University of Pennsylvania revealed an increase in the spread of vaccine misinformation.
- The limited use of COVID-19 vaccines is also affecting other vaccine manufacturers. In the U.S., only 14% of adults have received an updated COVID-19 vaccine for 2023-2024, according to the Centers for Disease Control and Prevention.
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Morgan Stanley bullish on biotech: That's why Pfizer and Co's shares could soon take off
boerse-online.de/nachrichten/aktien/morgan-stanley-bei-biotech-bullisch-darum-koennten-die-aktien-von-pfizer-und-co-bald-richtig-abgehen-20354537.html
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology: GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday ...
reut.rs/3UzZgE8
Pneumococcal vaccine: Apexxnar® becomes Prevenar 20®: The pneumococcal vaccine Apexxnar® is no longer only approved for adults aged 18 and over ...
ptaheute.de/aktuelles/2022/04/27/neuer-pneumokokken-impfstoff-fuer-erwachsene
Pfizer Receives FDA Approval for Bleeding Disorder Treatment: The treatment, Beqvez, is for adults with moderate to severe hemophilia B.
barrons.com/articles/pfizer-fda-bleeding-disorder-stock-price-dca9b947
Paid articlePaid
📸 “I'll give you €100 if, when she's finished on the phone, you ask Ursula if she was talking to that bloke from Pfizer.”
That's our caption contest entry ... Show more
Meet the world’s newest superheroes: Seagull Boy, Alcohol Man and the Incredible Kebab – POLITICO
Meet the world’s newest superheroes: Seagull Boy, Alcohol Man and the Incredible Kebab – POLITICO
Quarterly figures: Pfizer loss pushes WPP's balance sheet down: The advertising holding WPP has presented its business figures for the first quarter of 2024 ...
horizont.net/agenturen/nachrichten/quartalszahlen-pfizer-verlust-drueckt-die-bilanz-von-wpp-nach-unten-219520
Paid articlePaid
California Board OKs Drinking Water Standard for Hexavalent Chromium: California rule sets limits on a carcinogen that are the same as those invalidated in 2017 ...
enr.com/articles/58506-california-board-oks-drinking-water-standard-for-hexavalent-chromium
Paid articlePaid
Synch, breed and succeed in Emly, Co Tipperary: Dairy farmer Michael Ring outlines the breeding regime that has given his herd a huge boost ...
irishexaminer.com/sponsored/arid-41367967.html
California sets limit for chromium-6 in drinking water: California has set a limit for the toxic heavy metal hexavalent chromium in drinking water ...
latimes.com/environment/story/2024-04-18/california-chromium-6-water
Because large pharmaceutical companies have few active ingredients in the pipeline and many patents are expiring, the appetite for takeovers is increasing ... Show more
STOCK EXCHANGE ONLINE 16/24 - Börsenmedien AG
STOCK EXCHANGE ONLINE 16/24 - Börsenmedien AG
Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth: Pfizer announced positive results from a pivotal clinical trial evaluating Abrysvo's ...
seekingalpha.com/article/4684677-pfizer-stock-key-drivers-of-free-cash-flow-growth
Paid articlePaid Goldman Sachs: The experts are now betting on these new growth stocks: New high ROE growth stocks added by Goldman Sachs, including Amazon, Uber and Pfizer.
boerse-online.de/nachrichten/aktien/goldman-sachs-auf-diese-neuen-wachstumsaktien-setzen-die-experten-jetzt-20355554.html
Doubts about the Greek economic miracle: Greece is suffering from Europe's slump and needs further structural reforms. That is the tenor of the annual Delphi ...
faz.net/aktuell/wirtschaft/zweifel-am-griechischen-wirtschaftswunder-19651596.html
Paid articlePaid Pfizer's Doldrums, Just A Bad Case Of COVID-19?: Pfizer may be worth buying as the COVID-based product revenues decline and equilibrate ...
seekingalpha.com/article/4683994-pfizer-doldrums-just-a-bad-case-of-covid-19-pfe-stock
Paid articlePaid
Zoetis falls 8% after report that its arthritis shots may have sickened pets: Company says drugs are safe and effective, but can have side effects
marketwatch.com/story/zoetiss-stock-falls-7-to-lead-s-p-500-decliners-after-report-its-arthritis-shots-have-sickened-pets-cdef1d7d
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
AstraZeneca there: That's why these biotech stocks are now making hearts beat faster on Wall Street
boerse-online.de/nachrichten/aktien/astrazeneca-dabei-darum-lassen-diese-biotech-aktien-an-der-wall-street-jetzt-herzen-hoeher-schlagen--20354827.html
5 Top Dividend Stocks to Buy From the Best Managers: These cheap dividend stocks are popular among highly rated concentrated fund managers.
morningstar.com/stocks/5-top-dividend-stocks-buy-best-managers
Click here: A Patient-Centric Approach to Utilizing Oral SERDs for ER-Positive/HER2-Negative MBC Patients After First-Line Endocrine Therapy to view Accreditation and Disclosure details before participating.
Pharma requires innovation: Artificial intelligence, the proposed European drug legislation and the tackling of antimicrobial resistance were among the topics ...
ekathimerini.com/economy/1235810/pharma-requires-innovation/
Vaccine deal with Pfizer: Ursula von der Leyen in the sights of corruption hunters
rundschau-online.de/red/impfstoff-deal-mit-pfizer-von-der-leyen-im-visier-der-korruptionsjaeger-770493
Things are getting tight for Ursula von der Leyen: criminal investigators are looking into the Pfizer deal
berliner-zeitung.de/wirtschaft-verantwortung/es-wird-eng-fuer-ursula-von-der-leyen-strafermittler-untersuchen-pfizer-deal-li.2201815
Listen to the experts discuss cases from the clinic dealing with paroxysmal nocturnal hemoglobinuria and sickle cell disease ... Show more
A Rare Day in Community Hematology Clinic: Interesting Cases in Classical Hematology
A Rare Day in Community Hematology Clinic: Interesting Cases in Classical Hematology
European prosecutors target von der Leyen over vaccine deals: The European Public Prosecutor’s Office has become involved in the “Pfizergate” scandal involving ...
focus.de/politik/pfizergate-europaeische-staatsanwaelte-nehmen-von-der-leyen-wegen-impfstoff-deals-ins-visier_id_259817356.html
Investigation against von der Leyen over Pfizer deal: In 2021, the Commission President and Pfizer CEO Albert Bourla agreed a vaccine deal worth billions ...
nzz.ch/international/umstrittener-impfstoff-deal-nun-ermitteln-europas-korruptionsjaeger-gegen-ursula-von-der-leyen-ld.1824589
Paid articlePaid Astra, Pfizer Boost China Bets Despite US Drive to Decouple: The chief executive officers of AstraZeneca Plc and Pfizer Inc. pledged to support expansion of ...
bloomberg.com/news/articles/2024-03-26/astra-pfizer-double-down-on-china-investment-amid-us-tensions
Paid articlePaid Conservative groups object to 'naming names' rule from Pfizer diversity decision: Six right-leaning nonprofits have called on a U.S. appeals court to reconsider ...
reuters.com/legal/government/column-conservative-groups-object-naming-names-rule-pfizer-diversity-decision-2024-04-01/
Morningstar reveals: These 10 moat stocks are the most undervalued: This list of 10 stocks has it all. According to the US experts at Morningstar ...
boerse-online.de/nachrichten/aktien/morningstar-gibt-preis-diese-10-burggraben-aktien-sind-am-staerksten-unterbewertet-20354078.html
Zoetis Investigated for EU Antitrust Breach Over Dog Pain Drug: The European Commission is investigating whether US animal health company Zoetis Inc ...
bloomberg.com/news/articles/2024-03-26/zoetis-investigated-for-eu-antitrust-breach-over-dog-pain-drug
Paid articlePaid Pfizer offloads $3.9 bln stake in Sensodyne-maker Haleon: Haleon said on Tuesday top shareholder Pfizer offloaded a roughly $3.9 billion stake in the consumer ...
reuters.com/markets/deals/pfizer-offloads-39-bln-stake-sensodyne-maker-haleon-2024-03-19/
Boots to sell Covid-19 jabs in high street first - but they're not cheap: The single-dose Pfizer vaccine will be offered at 50 stores from April 1 to anyone aged ...
chroniclelive.co.uk/news/uk-news/boots-sell-covid-19-pfizer-28892311
After earnings plunge, BioNTech pins hopes on cancer drug launches: Germany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during ...
reuters.com/business/healthcare-pharmaceuticals/after-earnings-plunge-biontech-pins-hopes-cancer-drug-launches-2024-03-20/
Quick Glance: BioNTech Focuses on Cancer Drug Development after Revenue Plunge
- BioNTech reported a significant drop in revenue and earnings in 2023 as it shifts focus towards cancer drug development.
- The company aims for revenues between 2.5 billion to 3.1 billion euros in 2024.
- BioNTech plans to launch its first oncology drug in 2026 and secure ten indication approvals by 2030.
- Partner Pfizer anticipates a decline in sales for the COVID-19 vaccine, while BioNTech invests in scaling up its oncology business.
Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns
seekingalpha.com/article/4678774-pfizer-attractive-valuation-and-a-strong-pipeline-mitigate-patent-cliff-concerns
Paid articlePaid Pfizer Is Selling a Chunk of Its Haleon Stock. It’s a $3 Billion Windfall.: The sale comes as Pfizer’s need for cash has increased. It recently closed on its $43 ...
on.barrons.com/3II1UkH
Don't count us out yet, Novavax says: After losing the COVID vaccine race, it hopes a combination flu-COVID shot can help reverse its fortunes.
trib.al/B9FSzkd
Currys Lifts Profit Outlook After Bidders Walk Away: Get briefed ahead of your morning calls with the latest UK business headlines, key data and market reaction
bloomberg.com/news/newsletters/2024-03-18/currys-lifts-profit-outlook-after-bidders-walk-away-ltwoi347
Which NSAID Is Right for You? Here's What to Know: Popular over-the-counter pain and inflammation drugs have been a revelation for people with pain, swelling ...
webmd.com/pain-management/news/20240319/which-nsaid-is-right-for-you-what-to-know
Opinion: How should we deal with COVID now?: Debates about the latest quarantine rules miss what matters most to fight COVID in 2024.
latimes.com/opinion/story/2024-03-25/covid-vaccines-cdc-rules-paxlovid
Covid vaccine to be sold on high street for first time: Covid jabs will be sold on the high street for £99 from next week, as Boots becomes the first major ...
thetimes.co.uk/article/covid-vaccine-jab-high-street-uk-boots-gwvjsdzbz
Paid articlePaid Tylenol vs. Advil vs. Aleve: Which Is Best?: Learn about the differences between these popular OTC pain medications and which is best for headaches, fever ...
health.usnews.com/wellness/articles/tylenol-vs-advil-vs-aleve-which-is-best
London's FTSE 100 opens higher on miners' boost: The UK's FTSE 100 inched higher on Monday as metal miners rose on upbeat economic data from China ...
reuters.com/markets/europe/londons-ftse-100-opens-higher-miners-boost-2024-03-18/
Should be blonde and intelligent: Frédéric Prince of Anhalt is looking for a woman to have children with
n-tv.de/leute/Frederic-Prinz-von-Anhalt-sucht-Frau-zum-Kinderkriegen-article24813611.html
Opinion | Viagra Could Be Good for Your Brain: Artificial intelligence is allowing scientists to discover new uses for old medications.
on.wsj.com/3PpYEy0
In a pandemic milestone, the NIH ends guidance on COVID treatment: The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines ...
npr.org/sections/health-shots/2024/03/19/1239276507/nih-covid-treatment-guidelines
Microsoft fixes five security vulnerabilities in Edge 123: Microsoft has released a new update for Edge 123 in the Stable Channel. Version 123.0.2420 ...
neowin.net/news/microsoft-fixes-five-security-vulnerabilities-in-edge-123/
The Age of Respiratory Syncytial Virus Prevention: Empowering Pharmacists to Optimize Disease Protection in Older Adults
medscape.org/viewarticle/999447
Pfizer: Enormous competition: The market is considered competitive.
deraktionaer.de/artikel/pharma-biotech/pfizer-enorme-konkurrenz-20354418.html
Everett Seagen plant closure will cost 119 workers their jobs in June: The 119 impacted employees were working on the setup of the Seagen manufacturing plant in ...
seattletimes.com/business/everett-seagen-plant-closure-will-cost-119-workers-their-jobs-in-june/
Publicis New York hires new chief creative officer: Joe Mongognia will lead all creative across the Publicis New York office, including the newly won Pfizer ...
adage.com/article/agency-news/publicis-new-york-hires-joe-mongognia/2550746
Paid articlePaid
Romania still has 10 mln doses of COVID-19 vaccines expired or close to: Romania's minister of health, Alexandru Rafila, announced on April 1 that about 7 ...
romania-insider.com/romania-covid-vaccines-expired-april-2024
About 240 Mil. Unused COVID-19 Vaccine Doses to Be Discarded; Free Vaccination Program Ended
japannews.yomiuri.co.jp/society/coronavirus/20240402-178141/
European prosecutors take over Belgian probe into Pfizergate: European Public Prosecutor’s Office looking into texts between Ursula von der Leyen and boss of ...
politico.eu/article/pfizergate-covid-vaccine-scandal-european-prosecutors-eu-commission/
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics